Accelerating Precision Therapeutic Development with Clinico-Genomics
Introducing GenoSphere™, our centralized research data ecosystem built on deep genetic and longitudinal clinical data designed to optimize research and precision medicine development
Our comprehensive GenoSphere™ multimodal datasets are built on the world's most dynamic precision clinical research network with longitudinal clinical data and cutting-edge Exome+® sequencing from a diverse population of >300k records from a range of therapeutic areas including Autoimmune, Cardiovascular, Metabolic and much more. Our solutions are paired with world-class translational research expertise and an AI-enabled digital cohort builder tool, Explorer™ to support life science research and clinical development across the drug development lifecycle.
Built on 13+ years of longitudinal data across major therapeutic areas including CVRM, autoimmune, and more
Whole exome sequencing, linked to OMOP harmonized longitudinal clinical data (refreshed quarterly), enriched with medical, pharmacy, and mortality claims data
In-house team of experts to drive innovation with clinico-genomic data while ensuring integrity, accuracy and reliability
>300k
longitudinal clinico-genomic records with consent for recontact
~13 years
average longitudinal patient EHR history
2x growth
in network participants size in the last 12 months
>1M participants
Targeting >1M participants across North America by 2027
Providing deep insights from genetic and real-world data across a range of therapeutic areas to advance biomarker discovery, stratify patient populations, evaluate therapeutic efficacy and much more
Consisting of >35K individuals with conditions such as Lupus, Rheumatoid Arthritis, IBDs and more
Over 165K patients with cardiovascular, metabolic and renal conditions
World's largest specialized GLP-1 cohort consisting of over >35k patients on major GLP-1 agonists including Semaglutide, Tirzepatide and more
Cohort coming soon.
